Dexrazoxane hydrochloride - CAS 149003-01-0
Catalog number: 149003-01-0
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Dexrazoxane hydrochloride is an intracellular iron chelator, which decreases the formation of superoxide radicals, used as a cardioprotective agent.
Publictions citing BOC Sciences Products
  • >> More
ICRF-187 (ADR-529) HCl
1.Carfilzomib-induced cardiotoxicity mitigated by dexrazoxane through inhibition of hypertrophic gene expression and oxidative stress in rats.
Al-Harbi NO1. Toxicol Mech Methods. 2016 Mar;26(3):189-95. doi: 10.3109/15376516.2016.1143071. Epub 2016 Feb 21.
Carfilzomib (CFZ) is an inhibitor of proteasome that is generally used in the treatment of multiple myeloma but due to its cardiotoxicity clinical use may be limited. Dexrazoxane (DZR), an inhibitor of topoisomerase-II, prevents cardiac damage by reducing the formation of reactive oxygen species and hypertrophic gene expression. This study evaluated the protective effect of DZR on CFZ-induced cardiotoxicity. Thirty-two male Albino rats were randomly divided into four groups (n = 8). Group I received DMSO, Group II received CFZ (4 mg/kg, intraperitoneally [i.p.]) twice weekly up to day 16, Group III received DZR (20 mg/kg, i.p.) for 16 days and CFZ twice weekly for 16, Group IV received DZR (40 mg/kg, i.p.) for 16 days and CFZ twice weekly for 16. CFZ-induced cardiotoxicity was assessed by hematological, biochemical, mRNA expression, oxidative stress and histopathological studies. CFZ-induced significant changes have been observed in blood parameters including red blood cells, white blood cells, hemoglobin and hematocrit concentrations which were associated with increase in cardiac enzymes markers like creatine kinase (CK), CK-MB and lactate dehydrogenase.
2.Overview, prevention and management of chemotherapy extravasation.
Kreidieh FY1, Moukadem HA1, El Saghir NS1. World J Clin Oncol. 2016 Feb 10;7(1):87-97. doi: 10.5306/wjco.v7.i1.87.
Chemotherapy extravasation remains an accidental complication of chemotherapy administration and may result in serious damage to patients. We review in this article the clinical aspects of chemotherapy extravasation and latest advances in definitions, classification, prevention, management and guidelines. We review the grading of extravasation and tissue damage according to various chemotherapeutic drugs and present an update on treatment and new antidotes including dexrazoxane for anthracyclines extravasation. We highlight the importance of education and training of the oncology team for prevention and prompt pharmacological and non-pharmacological management and stress the availability of new antidotes like dexrazoxane wherever anthracyclines are being infused.
3.Oxidative stress does not play a primary role in the toxicity induced with clinical doses of doxorubicin in myocardial H9c2 cells.
Rharass T1,2, Gbankoto A3, Canal C1, Kurşunluoğlu G4, Bijoux A1, Panáková D2, Ribou AC5,6. Mol Cell Biochem. 2016 Feb;413(1-2):199-215. doi: 10.1007/s11010-016-2653-x. Epub 2016 Jan 30.
The implication of oxidative stress as primary mechanism inducing doxorubicin (DOX) cardiotoxicity is still questionable as many in vitro studies implied supra-clinical drug doses or unreliable methodologies for reactive oxygen species (ROS) detection. The aim of this study was to clarify whether oxidative stress is involved in compliance with the conditions of clinical use of DOX, and using reliable tools for ROS detection. We examined the cytotoxic mechanisms of 2 μM DOX 1 day after the beginning of the treatment in differentiated H9c2 rat embryonic cardiac cells. Cells were exposed for 2 or 24 h with DOX to mimic a single chronic dosage or to favor accumulation, respectively. We found that apoptosis was prevalent in cells exposed for a short period with DOX: cells showed typical hallmarks as loss of anchorage ability, mitochondrial hyperpolarization followed by the collapse of mitochondrial activity, and nuclear condensation. Increasing the exposure period favored a shift to necrosis as the cells preferentially exhibited early DNA impairment and nuclear swelling.
4.ReCAP: Detection of Potentially Avoidable Harm in Oncology From Patient Medical Records.
Lipitz-Snyderman A1, Weingart SN2, Anderson C2, Epstein AS2, Killen A2, Classen D2, Sima CS2, Fortier E2, Atoria CL2, Pfister D2, Lipitz-Snyderman A3, Weingart SN2, Anderson C2, Epstein AS2, Killen A2, Classen D2, Sima CS2, Fortier E2, Atoria CL2, Pfister J Oncol Pract. 2016 Feb;12(2):178-9. doi: 10.1200/JOP.2015.006874.
QUESTION ASKED: Although medical record-based measurement of adverse events (AEs) associated with cancer care is desirable, condition-specific triggers in oncology care are needed. We sought to develop a screening tool to facilitate efficient detection of AEs across settings of cancer care via medical record review. We hope to use this tool to understand the frequency, spectrum, and preventability of AEs with the goal of helping improve the quality and safety of cancer care.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products

CAS 71486-22-1 Vinorelbine

(CAS: 71486-22-1)

Vinorelbine, also called Navelbine, a 5′NOR semisynthetic vinca alkaloid which arrests tumor cell growth in metaphase by binding to tubulin and preventing form...

CAS 60482-95-3 Neurotensin(8-13)

(CAS: 60482-95-3)

Neurotensin (8-13), the smallest active fragment of neurotensin, results in a decrease in cell-surface NT1 receptors (NTR1) density.

CAS 662163-81-7 Importazole

(CAS: 662163-81-7)

Importazole is a cell-permeable inhibitor of importin-β. Importazole specifically inhibits the function of importin-β, likely by altering its interaction with R...

CAS 751-94-0 Sodium fusidate

Sodium fusidate
(CAS: 751-94-0)

Sodium fusidate is a bacteriostatic antibiotic. It suppresses nitric oxide lysis of pancreatic islet cells. It also inhibits protein synthesis in prokaryotes by...

CAS 121-32-4 Ethyl vanillin

Ethyl vanillin
(CAS: 121-32-4)

Ethyl vanillin, a kind of flavorant, could be commonly used in the production of food like chocolate. FEMA No: 2464.

(CAS: 1095110-48-7)

Ioforminol is a new low-osmolar dimeric radiographic contrast agent. It exhibits similar preclinical properties to other dimeric radiographic contrast media. It...

CAS 7753-60-8 Anecortave Acetate

Anecortave Acetate
(CAS: 7753-60-8)

Anecortave is a novel angiogenesis inhibitor. It can be used for the treatment of the exudative (wet) form of age-related macular degeneration. Anecortave posse...

CAS 3614-47-9 hydracarbazine

(CAS: 3614-47-9)

Hydracarbazine is a pyridazine that may increase the hypertensive activities of Acebutolol.

CAS 858350-62-6 AR 244555

AR 244555
(CAS: 858350-62-6)

AR 244555 is an inverse agonist of Mas G-protein signaling (IC50 values 186 and 348 nM in human and rat inositol phosphatase (IP) Gq coupling assays respectivel...

CAS 188627-80-7 Eptifibatide

(CAS: 188627-80-7)

A Arginin-glycin-aspartat-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events.

CAS 86227-47-6 all cis-5,8,11,14,17-Eicosapentaenoic Acid Ethyl Ester

all cis-5,8,11,14,17-Eicosapentaenoic Ac
(CAS: 86227-47-6)

all cis-5,8,11,14,17-Eicosapentaenoic Acid Ethyl Ester is an omega-3 fatty acid agent. It is important polyunsaturated fatty acid of the marine food chain. It s...

BMS 181168
(CAS: 123259-91-6)

This active molecular is an potential cognitive enhancer originated by Bristol-Myers Squibb. Mechanism of Action is not identified. Bmy 21502 is also a nootropi...

CAS 211110-63-3 Sobetirome

(CAS: 211110-63-3)

Sobetirome selectively binds to and activates TRbeta over TRalpha and this receptor selectivity led to the hypothesis that sobetirome would lower cholesterol th...

CAS 29679-58-1 Fenoprofen

(CAS: 29679-58-1)

Fenoprofen is a non-steroidal anti-inflammatory drug, act as an anti-inflammatory analgesic and antipyretic highly bound to plasma proteins.

CAS 130-86-9 Protopine

(CAS: 130-86-9)

Protopine, an isoquinoline alkaloid compound, is a Ca2+ channel blocker and could be used in immunoregulation.

Gepotidacin S enantiomer

Gepotidacin S enantiomer is an S enantionmer of gepotidacin which is a potent Type II DNA topoisomerase inhibitor and appears as a novel antibacterial drug cand...

CAS 20283-92-5 Rosmarinic acid

Rosmarinic acid
(CAS: 20283-92-5)

Rosmarinic acid is a naturally occurring hydroxylated compound occured in many plants. Rosmarinic acid exhibits agonist activity at GPR35 and shows antiviral, a...

CAS 41078-02-8 Enprofylline

(CAS: 41078-02-8)

Enprofylline, a xanthine derivative, is a a competitive nonselective phosphodiesterase inhibitor with relatively little activity as a nonselective adenosine rec...

CAS 369358-07-6 A 357300 hydrochloride

A 357300 hydrochloride
(CAS: 369358-07-6)

A 357300 hydrochloride is a potent and reversible inhibitor of methionine aminopeptidase-2 (MetAP-2). In murine models, it significantly inhibits CHP-134-derive...

(CAS: 865433-00-7)

Aladorianis is a ryanodine receptor calcium release channel modulator. It is an antiarrhythmic agent. Clinical development for Chronic heart failure and Ventric...

Chemical Structure

CAS 149003-01-0 Dexrazoxane hydrochloride

Quick Inquiry

Verification code

Featured Items